Financials
- Market Capitalization 433.08 M
- Employee 35
- Founded 1996
- CEO N/A
- Website www.fennecpharma.com
- Headquarter British Columbia, Canada
- FIGI BBG000DTH814
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-82.69
Fiyat/satışlar oranı
5.83
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2989 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.60 USD | +2.38% | -14.76% | +20.43% | +366.67% | 446.90 M USD | ||
| 3003 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.82 USD | -2.29% | -1.45% | -15.91% | -23.20% | 438.80 M USD | ||
| 3017 | CMPX Compass Therapeutics, Inc. - Common Stock | 2.39 USD | -0.42% | -0.42% | +23.20% | -30.72% | 430.41 M USD | ||
| 3019 | AVIR Atea Pharmaceuticals, Inc. - common stock | 5.35 USD | -0.19% | -2.90% | +13.11% | +66.67% | 429.10 M USD |